Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen J Bickston

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Gastroenterology & Hepatology|April 22, 2016
Endoscopic Evaluation of Microscopic ColitisStephen J Bickston
Inflammatory Bowel Diseases|May 29, 2003
Keeping the M in mind: recombinant human GMCSF and Crohn's diseaseStephen J Bickston
Gastroenterology & Hepatology|October 1, 2011
Infliximab for ulcerative colitis induction of remission and maintenance therapyStephen J Bickston
Expert Review of Clinical Immunology|July 3, 2010
Natalizumab for the treatment of Crohn's diseaseStephen J Bickston, Kishor Muniyappa
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 16, 2004
Optimal dosing of 5-aminosalicylic acid: 5 decades of choosing between politiciansStephen J Bickston, Fabio Cominelli
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 5, 2023
Higher Rates of Smoking Cessation as a Cause for a Rise in PouchitisStephen J Bickston, Harleen Kaur
Inflammatory Bowel Diseases|November 4, 2020
Financial Toxicity in People With Inflammatory Bowel DiseaseRichard S Bloomfeld, Stephen J Bickston
Inflammatory Bowel Diseases|April 22, 2022
Current Venous Thromboembolism Chemoprophylaxis Practices After Surgery for Inflammatory Bowel DiseasesStephen J Bickston, Michael V Patrone
Gastroenterology Clinics of North America|June 5, 2004
Treatment of luminal and fistulizing Crohn's disease with infliximabLawrence W Comerford, Stephen J Bickston
Gastroenterology Clinics of North America|November 30, 2006
Infliximab use in luminal Crohn's diseaseJames A Richter, Stephen J Bickston
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Gastroenterology & Hepatology|April 22, 2016
Endoscopic Evaluation of Microscopic ColitisStephen J Bickston
Inflammatory Bowel Diseases|May 29, 2003
Keeping the M in mind: recombinant human GMCSF and Crohn's diseaseStephen J Bickston
Gastroenterology & Hepatology|October 1, 2011
Infliximab for ulcerative colitis induction of remission and maintenance therapyStephen J Bickston
Expert Review of Clinical Immunology|July 3, 2010
Natalizumab for the treatment of Crohn's diseaseStephen J Bickston, Kishor Muniyappa
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 16, 2004
Optimal dosing of 5-aminosalicylic acid: 5 decades of choosing between politiciansStephen J Bickston, Fabio Cominelli
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 5, 2023
Higher Rates of Smoking Cessation as a Cause for a Rise in PouchitisStephen J Bickston, Harleen Kaur
Inflammatory Bowel Diseases|November 4, 2020
Financial Toxicity in People With Inflammatory Bowel DiseaseRichard S Bloomfeld, Stephen J Bickston
Inflammatory Bowel Diseases|April 22, 2022
Current Venous Thromboembolism Chemoprophylaxis Practices After Surgery for Inflammatory Bowel DiseasesStephen J Bickston, Michael V Patrone
Gastroenterology Clinics of North America|June 5, 2004
Treatment of luminal and fistulizing Crohn's disease with infliximabLawrence W Comerford, Stephen J Bickston
Gastroenterology Clinics of North America|November 30, 2006
Infliximab use in luminal Crohn's diseaseJames A Richter, Stephen J Bickston
Pageof 4